Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Paradigm Genetics, Inc. (NasdaqNM:PDGM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
108 Alexander Drive
Research Triangle Pk, NC 27709
Phone: (919) 425-3000
Fax: (919) 544-8094
Email: ir@paragen.com
Employees (last reported count): 210
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 71%
·Over the last 6 months:
 · one insider sell; 14.0K shares
·Institutional: 37% (129% of float)
(75 institutions)
·Net Inst. Buying: 977.0K shares (+9.05%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Paradigm Genetics, Inc. has industrialized the process of determining gene function to generate information that it believes will enable it and its commercial partners to develop novel products in four major sectors of the global economy: human health, nutrition, crop production, and industrial products. The Company has developed an industrialized, high throughput platform, known as the GeneFunction Factory, which is capable of determining the function of over a hundred plant and microbial genes per week. The Company is able to determine gene function at a rate far greater than that achieved historically. The Company believes this gives it an advantage in establishing intellectual property and developing new products.
More from Market Guide: Expanded Business Description

Financial Summary
Paradigm Genetics is industrializing the process of determining gene function by creating an assembly line process to generate information to enable the development of novel products in the crop, nutrition, human health and industrial markets. For the six months ended 6/30/01, revenues totaled $11.5 million, up from $2.3 million. Net loss applicable to Common fell 61% to $8.3 million. Results reflect revenues from the Bayer partnership, partially offset by higher R&D expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

G. Steven Burrill, 56
Chairman
--  
John Ryals, Ph.D., 47
Pres, CEO, Director
$378K
Ian Howes, 42
VP- Fin. and Operations, CFO, Treasurer
234K
Henry Nowak, 45
VP of Intellectual Property, Gen. Counsel, Sec.
--  
James Bucci, 56
VP of HR
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:PDGMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$3.516
Recent Price$6.43 
52-Week High
on 6-Oct-2000
$28.563
Daily Volume (3-month avg)95.0K
Daily Volume (10-day avg)21.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-62.5%
52-Week Change
relative to S&P500
-49.6%
Share-Related Items
Market Capitalization$169.5M
Shares Outstanding26.4M
Float7.60M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.22 
Earnings (ttm)-$0.63 
Earnings (mrq)-$0.16 
Sales (ttm)$0.75 
Cash (mrq)$0.91 
Valuation Ratios
Price/Book (mrq)5.25 
Price/EarningsN/A 
Price/Sales (ttm)8.54 
Income Statements
Sales (ttm)$19.6M
EBITDA (ttm)-$18.1M
Income available to common (ttm)-$16.5M
Profitability
Profit Margin (ttm)-84.3%
Operating Margin (ttm)-89.0%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-22.74%
Return on Equity (ttm)-41.81%
Financial Strength
Current Ratio (mrq)1.18 
Debt/Equity (mrq)0.51 
Total Cash (mrq)$23.8M
Short Interest
As of 8-Aug-2001
Shares Short465.0K
Percent of Float6.1%
Shares Short
(Prior Month)
465.0K
Short Ratio6.28 
Daily Volume74.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.